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Abstract In this study we report that the multidrug resistance 
protein (MRP) transports calcein from the cytoplasmic ompart- 
ment of tumor cells, in contrast to P-glycoprotein which trans- 
ports calcein acetuxymethyl ester from the plasmamembrane. 
The transport of calcein by MRP is ATP-dependent and is inhib- 
ited by probenecid and vincristine. Intracellular glutathione 
(GSH) depletion which occurred when cells were exposed to 
buthionine sulfoximine had no effect on the efflux of calcein, 
whereas it reversed the daunorubicin accumulation deficit in 
MRP overexpressing tumor cells. In conclusion, ATP-dependent 
transport of calcein and possibly other organic anions by MRP 
is not inhibited by a large decrease of the intracellular GSH 
concentration, that inhibits daunorubicin efflux by MRP. 
Key words: Multidrug resistance protein; P-glycoprotein; 
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I. Introduction 
The development of resistance of tumor cells to a wide range 
of natural anticancer agents, such as certain anthracyclines, 
actinomycin D, vinca alkaloids and etoposide generally iscalled 
multidrug resistance (MDR) [1,2]. One type of MDR is due to 
the overexpression of plasma membrane drug transporters, 
which act as ATP-dependent drug efflux pumps, resulting in 
lower intracellular drug concentrations and, hence, in drug 
resistance [1,3]. Hitherto, two different plasma membrane drug 
transporters have been cloned, namely the MDR1 encoded 
P-glycoprotein (Pgp) [4] and the recently discovered multidrug 
resistance protein (MRP) [5]. Both Pgp and MRP belong to the 
ATP-binding cassette (ABC) superfamily of membrane trans- 
port proteins [6]. However, the mechanism of drug transport 
by MRP differs considerably from that by Pgp. First of all, 
MRP and Pgp do not result in exactly the same spectrum of 
drug resistance. Pgp mediated MDR shows cross-resistance to 
taxol and mitoxantrone, whereas MRP causes very little cross- 
resistance to taxol and mitoxantrone [7,8]. MRP, but not Pgp, 
causes cross-resistance to some heavy metal ions such as arsen- 
ite and antimonials [8]. Furthermore, Pgp mediated MDR, in 
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contrast to MRP mediated MDR, is readily reversed by drugs 
such as verapamil, cyclosporin A and the cyclosporin analogue 
PSC833 [9]. A potent specific inhibitor of MRP mediated aun- 
orubicin (DNR) transport is the isoflavonoid genistein [9]. 
Another important difference between the two transporters 
seems to be the role of glutathione (GSH). GSH depletion by 
exposing of cells to buthionine sulfoximine (BSO), a potent 
inhibitor of GSH synthesis, increases the accumulation of 
daunorubicin (DNR), vincristine (VCR) and rhodamine insev- 
eral MRP, but not in Pgp MDR cells [10,11]. Since it is de- 
scribed that GSH S-conjugates and leukotriene C4 (LCT4) are 
transported by MRP [12] it is suggested that MRP is either 
identical to the GSH-S-conjugate export carrier (GS-X pump) 
or is able to activate an endogenous GS-X pump activity [13]. 
In the present study the mechanism oftransport of MRP was 
further characterized using the fluorescent dye calcein. Previ- 
ously it was shown that Pgp overexpressing cells have an accu- 
mulation defect for calcein when they are loaded with calcein 
acetoxy-methyl ester (calcein-AM) [14]. Calcein-AM is a lipo- 
philic, non-fluorescent compound, which rapidly permeates the 
plasma membrane ofcells and upon cleavage of the ester bonds 
by intracellular esterases i  transformed into the highly fluores- 
cent organic anion calcein. It is of interest to note that due to 
the different fluorescent properties of calcein-AM and calcein, 
information can be obtained about the compartment (cyto- 
plasm or plasma membrane) from which this dye is extruded 
by a drug transporter. In addition, it is suggested that Pgp 
transports calcein-AM directly from the cell plasma membrane 
compartment since calcein-AM, and not calcein, stimulates the 
vanadate-sensitive ATP-ase activity in isolated cell membranes 
of Pgp overexpressing insect cells [15]. Here we provide evi- 
dence that MRP actively transports calcein from the cytoplasm. 
2. Materials and methods 
2.1. Cell lines 
The human epidermoid carcinoma Pgp MDR cell line KB8-5 was 
obtained from ATCC, Rockville, MD. The non-small lung cancer cell 
line SW-1573 and its Pgp MDR subline SW-1573/2R160 have been 
described previously [16]. SW- 1573 (S 1) cells tably transfected with the 
MDR1 gene or the MRP gene were obtained from Dr. F. Baas and Dr. 
G.J.R. Zaman (Neth. Cancer Inst.) [7]. These cell lines were cultured 
in Dulbecco's MEM (Flow labs, Irvine, Scotland) supplemented with 
7.5% heat-inactivated fetal calf serum (FCS) (Gibco Europe, 
Paisley, Scotland). The human acute myeloblastic leukemia cell line 
HL60 and its MRP overexpressing subline HL60/ADR were obtained 
from Dr. M. Center [17]. The human small cell lung cancer cell line 
GLC 4 and its MRP overexpressing subline GLCa/ADR have been 
characterized before [18]. The GLC4 and HL60 and their sublines were 
cultured in RPMI 1640 (Flow labs, Irvine, Scotland) supplemented with 
10% FCS. All resistant cells were cultured in the presence ofa selecting 
drug (SW-1573(MRP) with G418) until 2-10 days before xperiments 
were performed. The cell ines were mycoplasma-free as tested regularly 
with the Mycoplasma T.C. kit (Gen-Probe Inc., San Diego, CA, USA). 
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2.2. Calcein efflux and DNR accumulation 
Parental and MRP MDR (0.3~).7 × 10 6) cells were loaded with 
0.5/IM calcein-AM and Pgp MDR cells with 0.5/IM calcein-AM and 
25 pM verapamil (Vp) for 10 min at 37°C (Molecular Probes, Inc, 
Eugene, USA) in medium A (growth medium without phenol red and 
bicarbonate buffer, but with 20 mM HEPES) + 10% FCS. After the 
incubation cells were washed in ice-cold medium A + 10% FCS and 
incubated in drug-free medium + 10% FCS with and without he rele- 
vant modulator. As a modulator 100 pM VCR (Sigma Chemical Com- 
pany, St. Louis, MO, USA) [19] or probenecid in the concentration f
0.5 and 1 mM (Sigma) was used for parental and MRP MDR cells and 
25/IM Vp was used for Pgp MDR cells. The efflux was stopped by 
centrifugation of the cells and by adding ice-cold medium. 
To measure DNR accumulation (0.3~).7 x 10 6) cells were incubated 
for 60 min at 37°C with 2 pM DNR (Sigma) with or without a modu- 
lator in medium A + 10% FCS. After the incubation cells were washed 
and resuspended in ice-cold medium A + 10% FCS. Non-specific bind- 
ing of calcein and DNR was measured by adding ice-cold rug contain- 
ing medium to the cells and washing them immediately. The fluores- 
cence of these dyes was analyzed with a FACScan flow cytometer 
(Becton Dickinson Medical Systems, Sharon, MA, USA) equipped 
with a laser excitation wavelength of 488 nm. The fluorescence of 
calcein was logarithmically measured with a 530 nm band-pass filter 
and the fluorescence of DNR was measured with a 575 nm filter. 
2.3. GSH and ATP depletion 
In order to assess if calcein was effluxed in an ATP-dependent way, 
we decreased the cellular ATP concentrations bypre-incubating of cells 
for 15 min at 37°C in medium A without glucose but containing 10 mM 
sodium azide and 5 mM deoxyglucose (medium C). In this medium the 
ATP concentration is decreased to 10~15% of the initial concentration 
[20]. After loading the cells with calcein-AM in medium C, the efflux 
of calcein was measured in medium A and C. 
In order to examine the effect of glutathione depletion by BSO on 
calcein efflux and DNR accumulation, cells were cultured in the pres- 
ence of 25 pM BSO for 20 h. Intracellular non-protein thiol (largely 
GSH) was measured with 5,5'-dithiobis(-2-nitrobenzoic acid)(Ellman's 
reagent; Boehringer Mannheim) in the supernatant of TCA precipi- 
tated cells [21,22]. 
3.  Resu l ts  
In order to test whether calcein was effluxed by MRP we 
have loaded parental and MRP overexpressing cells with cal- 
cein-AM, which is converted in the cytoplasm of the cell into 
the fluorescent dye calcein and we measured the efflux of cal- 
cein from the cells. Fig. la and lb show that in the parental cell 
lines HL60 and GLC4, which have a low endogenous MRP 
level, little efflux of calcein was detected (tl/2 > 90 min). The 
efflux of calcein was much faster in the MRP overexpressing 
cell lines HL60/ADR and the GLC4/ADR compared to the 
corresponding parental cell lines (tl/2 < 20 min). Furthermore, 
these figures show that the efflux of calcein was completely 
blocked in glucose-flee medium with 10 mM sodium azide and 
5 mM deoxyglucose, which leads to cellular ATP depletion. In 
the strongly Pgp overexpressing cell line SW-1573/2R160 [16] 
we did not find an increased ATP-dependent calcein efflux 
compared to the parental cell line SW-1573 (not shown), which 
is in accordance with the finding that calcein did not stimulate 
vanadate-sensitive ATPase activity in isolated Pgp containing 
cell membranes [15]. The slight effect of ATP depletion in 
parental and Pgp MDR cells is not due to the effect of a lower 
cytoplasmic pH after ATP depletion, since calcein transport is 
pH independent between pH 7.0 and 7.8 [14]. These results 
strongly suggest hat calcein is actively transported by MRP 
from the cytoplasmic ompartment after it has been formed 
from calcein-AM by cytoplasmic esterases. 
The fact that we found that calcein, which has a net negative 
charge, was transported from the cytoplasmic ompartment by 
MRP overexpressing cells might be in line with the hypothesis 
that positively charged drugs, such as anthracyclines, have to 
be conjugated with GSH in order to be transported by MRP. 
To gain more insight into the role of GSH in relation to drug 
transport by MRP, we examined the effects of GSH depletion 
on the efflux of calcein in several parental, and in Pgp and MRP 
overexpressing MDR cells. We decreased the GSH concentra- 
tion by culturing cells during 20 h with 25 pM BSO [21]. The 
concentration of GSH was decreased to 28% in GLC4, 18% in 
GLC4/ADR, 20% in HL60, 16% HL60/ADR cells (percentage 
of controls; means of at least 2 exp). As a control for the 
effectiveness of GSH depletion, we measured its effect on DNR 
accumulation since it was reported that the accumulation defect 
of DNR in MRP MDR cells can be reversed by GSH depletion 
[21]. In addition, we compared the effect of GSH depletion with 
the effect of transport modulators on the DNR accumulation 
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Fig. 1. Efflux of calcein and the effect of energy depletion on the efflux in various parental (circles) and MRP (triangles). Cells were pre-incubated 
for 15 min in medium C and then loaded for 10 min with 0.5pM calcein-AM in medium C at 37°C. Efflux of calcein was measured after suspending 
cells in calcein-AM-free medium at 37°C in medium A (open symbols) and medium C (closed symbols). Data are means of two independent 
experiments. 
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Table 1 
Effect of GSH depletion and modulators on the accumulation ofDNR 
DNR accumulation 
Effect of modulator Effect of BSO 
Parental cell lines 
SW-1573 1.05 + 0.19 1.17 + 0.10 
HL60 0.93 + 0.03 0.94 + 0.03 
GLC4 1.05 + 0.09 0.93 + 0.16 
Pgp MDR cell lines 
KB8-5 2.07 + 0.54 1.05 + 0.06 
SW-157312R160 11.88 + 2.36 1.07 + 0.07 
MRP MDR cell lines 
HL60/ADR 2.51 + 0.27 2.42 + 0.26 
GLC4/ADR 2.89 + 0.40 3.42 + 1.91 
Data are means + S.D. of at least hree independent experiments. GSH 
depletion was achieved by culturing cells during 20 h with 25 pM BSO. 
100 ¢tM VCR was used as a modulator for parental and MRP MDR 
cells and 25/IM Vp was used for Pgp MDR cells. The effect of modu- 
lator or GSH depletion is the ratio of DNR accumulation with modu- 
lator or in GSH-depleted cells divided by DNR accumulation i  control 
cells. 
could reverse the DNR accumulation to the same extent as the 
modulator VCR in MRP MDR cells, showing its effectiveness 
in modulating DNR transport by MRP. In parental and Pgp 
MDR cells no effect of GSH depletion by BSO was found on 
the DNR accumulation. However, Table 2 shows that GSH 
depletion had no effect on the amount of  calcein effluxed from 
the MRP MDR cell line GLC4/ADR (ratio of calcein retention 
after BSO divided by control was 0.93) and had a slight effect 
in HL60/ADR (a ratio of 1.25) whereas the modulator VCR 
had a large inhibitory effect on the efflux of calcein (a ratio of 
2.18 and 3.96 in GLC4/ADR and HL60/ADR respectively). 
Thus, these results obtained with the highly MRP overex- 
pressing GLC4/ADR and HL60/ADR cells suggest that the 
ATP-dependent transport of calcein in these cell lines is not 
dependent on intracellular GSH concentrations. 
To obtain more evidence for the role of MRP in calcein efflux 
we have performed experiments using SW-1573 cells, stably 
transfected with the MRP gene and tested the organic anion 
probenecid as blocker of the calcein efflux in these transfected 
cells as well as in the MRP overexpressing GLC JADR and 
HL60/ADR cells. Since the resistance of the MRP transfected 
cells is small compared to the other cell lines [7], as a control 
for these experiments the SW-1573(MDR1) transfected cells 
were used, which have resistance factors similar to the MRP 
transfected cells. Table 3 shows that the efflux of calcein was 
much faster in the SW-1573(MRP) cells, which results in a 
lower retention in these MRP transfected cells, compared to the 
parental SW-1573 and Pgp MDR SW-1573(MDR1) cells. In 
addition, Table 2 shows that 1 mM probenecid has a large 
inhibitory effect on calcein efflux in GLC4/ADR, HL60/ADR 
and SW-1573(MRP) cells, whereas it has a slight effect in the 
parental and in the SW-1573(MDR1) cells. Notably, 1 mM 
probenecid inhibited the efflux of calcein for almost 100% in 
the MRP overexpressing cells. A lower concentration of probe- 
necid (0.5 mM) had an effect comparable to that of 100/2M 
VCR (not shown). Also, in contrast o the effect of probenecid 
and VCR, GSH depletion by BSO exposure (to 34% of control) 
had no effect on the efflux of calcein in the MRP transfected 
SW-1573(MRP) cells. These results show that the MRP medi- 
ated efflux of calcein can be inhibited by VCR and the organic 
Table 2 
Effect of GSH depletion and modulators on the efflux of calcein 
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Calcein efllux 
Effect of Effect of Effect of 
probenecid vincristine BSO 
Parental cell lines 
SW-1573 1.18 + 0.03 1.10 + 0.12 0.93 _+ 0.10 
HL60 1.30 + 0.08 1.20 + 0.09 0.94 + 0.02 
GLC 4 1.10 + 0.03 1.10 + 0.05 1.01 + 0.04 
Pgp MDR cell lines 
KB8-5 n.d. 1.07 + 0.03 1.01 + 0.06 
SW-1573/2R160 n.d. 1.06 + 0.061 1.05 + 0.07 
SW-1573 (MDR1) 1.14 + 0.02 1.24 + 0.14 n.d. 
MRP MDR cell lines 
SW-1573(MRP) 3.70 + 0.80 1.90 + 0.30 1.07 + 0.07 
HL60/ADR 3.70 + 0.28 3.96 + 0.49 1.25 + 0.07 
GLC4/ADR 3.05 + 0.39 2.18 + 0.13 0.93 + 0.09 
Data are means + S.D. of at least three independent experiments; n.d. 
is not determined. GSH depletion was achieved by culturing cells dur- 
ing 20 h with 25/.tM BSO. The effect of modulator (1 mM probenecid, 
100 pM VCR or 25 pM verapamil for 2R160 cells ~) or GSH depletion 
is the ratio of the retention of calcein with modulator or in GSH- 
depleted cells divided by the retention of calcein in control cells after 
60 min of calcein efflux. 
anion transport inhibitor probenecid, but is not sensitive to a 
large decrease in intracellular GSH concentration. 
4. Discussion 
This study gives evidence that the organic anionic dye calcein 
is actively transported from the cytoplasmic ompartment of 
cells by MRP leading to a decreased accumulation of calcein 
in MRP MDR cells. However, the decreased accumulation of 
calcein in Pgp MDR cells as shown before [14], is not caused 
by the transport of calcein but by the transport of the lipophilic 
calcein-AM ester directly from the cellular plasma membrane. 
Probably, calcein-AM is transported by Pgp due to the rela- 
tively hydrophobic tails of the ester groups, which contain a 
basic nitrogen atom and an extended side chain, a combination 
which is often present in Pgp modulatory compounds. Thus, 
the accumulation defect of calcein in Pgp and MRP MDR cells 
is largely the result of different pharmacological characteristics 
of the Pgp and MRP transporters. In addition, it could still be 
that part of the accumulation defect of calcein in MRP overex- 
pressing cells is also due to the transport of calcein-AM by 
MRP. 
Since calcein is a strongly negatively charged molecule (net 
charge is approximately -4  at pH 7.0), the transport of calcein 
by MRP is in accordance with the recent finding that MRP acts 
Table 3 
Retention of calcein in SW-1573 and transfected cells 
Calcein retention 
After 30 min (%) After 60 min (%) 
SW-1573 85 + 10 70 _+ 5 
SW-1573(MDR1) 84 + 4 73 _+ 5 
SW-1573(MRP) 29 + 2 18 + 4 
Cells were loaded for 10 min with 0.5 pM calcein-AM after which 
calcein efflux was measured. Data are means _+ S.D. of three inde- 
pendent experiments. 
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as a multispecific organic anion transporter (MOAT) [13]. Also, 
the inhibition of calcein transport by the organic anion pro- 
benecid would be consistent with that suggestion. In fact, Jed- 
litschky et al. [23] and Mfiller et al. [13] found that transport 
of LTC 4 and S-dinitrophenylglutathione was increased in mem- 
brane vesicles from the HL60/ADR and GLC4/ADR cells com- 
pared to vesicles from the parental drug sensitive cells. Because 
of the identification of MRP as MOAT, it has been suggested 
that positively charged and neutral drugs such as DNR and 
etoposide, respectively, which are actively transported by MRP 
[20], might be transported after conjugation with GSH or other 
negatively charged groups [13,23]. However, this is an unlikely 
explanation since hitherto such conjugates of anthracyclines 
have not been found to be formed in tumor cell lines in any 
substantial mount [24]. Also, a rapid conversion of etoposide 
(VP-16) would have to take place if a VP-16 conjugate would 
have to account for the very rapid ATP-dependent transport 
of VP-16 from MRP overexpressing GLC4/ADR cells [25]. 
Alternative xplanations for the GSH requirement of the 
transport of positively charged or neutral drugs by MRP, de- 
rived from the results of GSH depletion experiments may be 
that GSH depletion has some other side effects. One possible 
effect of BSO exposure could be that the plasma membrane is
damaged by oxidative stress due to a decreased protection by 
GSH, resulting in an increased rug influx and reversal of 
resistance. An endogenous inhibitor of MRP function might 
also be activated by GSH depletion. Our present results, which 
show that calcein transport by MRP is not inhibited by GSH 
depletion after BSO exposure, exclude above mentioned possi- 
ble other effects of GSH depletion. Thus, the different effects 
of GSH depletion on transport of negatively charged (calcein) 
and positively charged molecules (DNR, VCR, rhodamine) 
strengthen the hypothesis that MRP transports negatively 
charged molecules. GSH could be needed as co-substrate or 
indirect stimulator for transport of positively charged drugs, 
but not or at a very low concentration for transport of nega- 
tively charged molecules by MRE 
In conclusion, this study demonstrates that calcein is trans- 
ported from the cytoplasmic compartment of the cell by MRP, 
but not by Pgp, in an ATP-dependent way. The transport of 
calcein is inhibited by VCR and the organic anion transport 
inhibitor probenecid but not by a lowered intracellular GSH 
concentration, which is probably due to the fact that calcein is 
negatively charged. The relative importance of the charge of 
molecules for their transport by MRP has to be further investi- 
gated using molecules which differ in charge. 
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